Amy Sullivan - Oct 17, 2022 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
Chief Financial Officer
Signature
/s/ Brian Burkavage, Attorney-in-Fact for Amy Sullivan
Stock symbol
IOBT
Transactions as of
Oct 17, 2022
Transactions value $
$0
Form type
4
Date filed
10/19/2022, 04:54 PM
Previous filing
Oct 19, 2022
Next filing
Mar 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOBT Stock Option (Right to Buy) Award $0 +288K $0.00 288K Oct 17, 2022 Common Stock 288K $2.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of these options vest on 10/15/2023, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control.